TABITHA SPATARO: Open Payments
NPI 1902662604 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 27 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $143 |
| Collegium Pharmaceutical, Inc. | 10 | $138 |
| Valinor Pharma, LLC | 3 | $46 |
| AppliedVR Inc | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Forte Bio-Pharma LLC | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: RELISTOR, Belbuca, MOVANTIK, RelieVRx, PURIFIED CORTROPHIN GEL, PROLATE, JOURNAVX.
Industry payments across OK — which companies pay providers there.
